Research
Search
Close
YANG Zhili
- Graduate Supervisor, Associate Chief Physician
- Department: General Surgery
- Research Area: Surgery (General Surgery)
- Research Interests: Clinical and basic research on thyroid cancer and abdominal wall hernia
- Contact: yangzhililaoshi@126.com
- MD from Shanghai Jiao Tong University School of Medicine, 2010
- MM from Central South University XiangYa School of Medicine, 2003
- MB from Hunan Medical University, 1997
- Associate Chief Physician, Department of General Surgery, Shanghai Sixth People's Hospital
- Tang Y, Yan T, Qiu W, Ding Z, Fan Y, Jiao Q#, Yang Z#. Surgery is a Viable Treatment Option for Stage IE Primary Thyroid Lymphoma. Annals of surgical oncology, 2024, doi: 10.1245/s10434-023-14535-8.
- Weng H, Yan T, Qiu W, Fan Y, Yang, Z#. The Prognosis of Skip Metastasis in Papillary Thyroid Microcarcinoma Is Better Than That of Continuous Metastasis. The Journal of clinical endocrinology and metabolism, 2022, doi: 10.1210/clinem/dgac107.
- Yan T, Qiu W, Weng H, Fan Y, Zhou G#, Yang Z#. Single-Cell Transcriptomic Analysis of Ecosystems in Papillary Thyroid Carcinoma Progression. Frontiers in endocrinology, 2021, doi: 10.3389/fendo.2021.729565.
- Yan T, Qiu W, Song J, Fan Y, Yang Z#. ARHGAP36 regulates proliferation and migration in papillary thyroid carcinoma cells. Journal of molecular endocrinology, doi: 10.1530/JME-20-0230.
- Song J, Qiu W, Yan T, Wu B, Guo M, Fan Y#, Yang Z#. Comparison of Lobectomy and Total Thyroidectomy in Unilateral Papillary Thyroid Microcarcinoma Patients with Ipsilateral Lateral Lymph Node Metastasis Without Gross Extrathyroidal Extension. World journal of surgery, 2020, doi: 10.1007/s00268-020-05514-1.
- 07/01/2021-06/30/2024
Natural Science Foundation of Shanghai, ¥200,000, 21ZR1448500
Cancer-associated myofibroblast subpopulation via TNFAIP6 promotes the formation of metastatic microenvironment of papillary thyroid cancer
Role: Project leader - 01/01/2015-12/31/2018
National Natural Science Foundation of China, ¥720,000, 81472499
Mechanisms of acquired radioactive iodine refractory in differentiated thyroid carcinoma by whole-exome sequencing of plasma
Role: Project leader
